These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8723167)
41. Effects of tilisolol, a nonselective beta-adrenergic blocker, on the membrane currents of isolated guinea pig ventricular myocytes. Takagi S; Kihara Y; Mitsuiye T; Wang Z; Sasayama S J Cardiovasc Pharmacol; 1997 May; 29(5):593-8. PubMed ID: 9213200 [TBL] [Abstract][Full Text] [Related]
42. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Vatner SF; Hintze TH Circulation; 1982 Sep; 66(3):579-88. PubMed ID: 6124327 [TBL] [Abstract][Full Text] [Related]
43. Role of K(+)(ATP) channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle. Melchert PJ; Duncker DJ; Traverse JH; Bache RJ Am J Physiol; 1999 Aug; 277(2 Pt 2):H617-25. PubMed ID: 10444487 [TBL] [Abstract][Full Text] [Related]
44. Vasodilating effect of the new beta-blocker tilisolol hydrochloride in humans. Imaizumi T; Takeshita A; Nakamura N; Hirooka Y; Suzuki S; Yoshida M; Nakamura M Arzneimittelforschung; 1988 Sep; 38(9):1342-4. PubMed ID: 2906248 [TBL] [Abstract][Full Text] [Related]
45. Adenosine- and hypoxia-induced dilation of human coronary resistance arteries: evidence against the involvement of K(ATP) channels. Lynch FM; Austin C; Heagerty AM; Izzard AS Br J Pharmacol; 2006 Feb; 147(4):455-8. PubMed ID: 16341231 [TBL] [Abstract][Full Text] [Related]
46. Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs. Noguchi K; Kato T; Kinjo N; Moromizato H; Sakanashi M Jpn J Pharmacol; 1990 Jul; 53(3):381-91. PubMed ID: 1697348 [TBL] [Abstract][Full Text] [Related]
47. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs. Giudicelli JF; la Rochelle CD; Berdeaux A J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761 [TBL] [Abstract][Full Text] [Related]
48. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424 [TBL] [Abstract][Full Text] [Related]
49. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619 [TBL] [Abstract][Full Text] [Related]
50. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs. Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761 [TBL] [Abstract][Full Text] [Related]
51. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs. Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239 [TBL] [Abstract][Full Text] [Related]
54. Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs. Drieu la Rochelle C; Berdeaux A; Richard V; Giudicelli JF J Cardiovasc Pharmacol; 1991 Dec; 18(6):904-10. PubMed ID: 1725905 [TBL] [Abstract][Full Text] [Related]
55. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. Auchampach JA; Maruyama M; Cavero I; Gross GJ J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089 [TBL] [Abstract][Full Text] [Related]
56. Effects of a new beta-adrenoceptor blocking agent, S-596 (arotinolol), on isolated dog coronary arteries. Sakanashi M; Miyamoto Y; Takeo S; Noguchi K Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):208-16. PubMed ID: 6192776 [TBL] [Abstract][Full Text] [Related]
57. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation. Feliciano L; Henning RJ J Auton Nerv Syst; 1998 Jan; 68(1-2):78-88. PubMed ID: 9531447 [TBL] [Abstract][Full Text] [Related]
58. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711 [TBL] [Abstract][Full Text] [Related]
59. Vasodilator effects of PGE1 in the coronary and systemic circulation of the rat are mediated by ATP-sensitive potassium (K+) channels. Ney P; Feelisch M Agents Actions Suppl; 1995; 45():71-6. PubMed ID: 7536384 [TBL] [Abstract][Full Text] [Related]